Recovery and Survival of Buffy Coat-Derived Platelets Stored for 7 Days in Plasma or Additive Solution

被引:0
作者
Cardigan, R. [1 ]
Cooke, L. [1 ]
Cookson, P. [2 ]
Wiltshire, M. [2 ]
Williamson, L. M. [1 ]
机构
[1] NHS Blood & Transplant, Cambridge, England
[2] NHS Blood & Transplant, Brentwood, Essex, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:86A / 86A
页数:1
相关论文
共 50 条
  • [41] BUFFY COAT DERIVED PLATELET CONCENTRATES STORED IN PLASMA, PLASMA-LYTE-A AND PAS-II
    HAWKER, RJ
    MITCHELL, SG
    TURNER, VS
    TRANSFUSION, 1995, 35 (10) : S36 - S36
  • [42] In vitro variables of buffy coat-derived platelet concentrates with residual plasma of down to 10% are stably maintained in new-generation platelet additive solutions
    Gravemann, Ute
    Volgmann, Thorsten
    Min, Kyungyoon
    Philipp, Roman
    Lambrecht, Bernd
    Mueller, Thomas H.
    Seltsam, Axel
    TRANSFUSION, 2015, 55 (07) : 1700 - 1709
  • [43] Therapeutic efficacy of pooled buffy-coat platelet components prepared and stored with a platelet additive solution
    van Rhenen, DJ
    Gulliksson, H
    Cazenave, JP
    Pamphilon, D
    Davis, K
    Flament, J
    Corash, L
    TRANSFUSION MEDICINE, 2004, 14 (04) : 289 - 295
  • [44] Bioactive substances in buffy-coat-derived platelet pools stored in platelet-additive solutions
    Edvardsen, L
    Taaning, E
    Mynster, T
    Hvolris, J
    Drachman, O
    Nielsen, HJ
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 103 (02) : 445 - 448
  • [45] Buffy coat-derived platelets cryopreserved using a new method: Results from a pivotal clinical trial on thrombocytopenic patients with acute leukaemia
    Napolitano, Mariasanta
    Mancuso, Salvatrice
    Raso, Simona
    LoCoco, Lucio
    Arfo, Piera Stefania
    De Francisci, Giovanni
    Dieli, Francesco
    Caccamo, Nadia
    Reina, Amalia
    Dolce, Alberto
    Agliastro, Rosalia
    Siragusa, Sergio
    TRANSFUSION AND APHERESIS SCIENCE, 2019, 58 (06)
  • [46] In vitro and in vivo evaluation of apheresis platelets stored for 5 days in 65% platelet additive solution/35% plasma
    Vassallo, Ralph R.
    Adamson, John W.
    Gottschall, Jerome L.
    Snyder, Edward L.
    Lee, Wanda
    Houghton, Jaime
    Elfath, M. Dean
    TRANSFUSION, 2010, 50 (11) : 2376 - 2385
  • [47] In Vitro Variables of Buffy Coat-derived Platelet Concentrates with Residual Plasma levels of down to 10% are Stably Maintained in Late-Generation Platelet Additive Solutions
    Gravemann, U.
    Volgmann, T.
    Philipp, R.
    Lambrecht, B.
    Mueller, T. H.
    Seltsam, A.
    TRANSFUSION, 2014, 54 : 96A - 97A
  • [48] SURVIVAL AND RECOVERY OF HUMAN-PLATELETS STORED FOR 5 DAYS IN A NONPLASMA MEDIUM
    ADAMS, GA
    SWENSON, SD
    ROCK, G
    BLOOD, 1986, 67 (03) : 672 - 675
  • [49] Removal of citrate from PAS-III additive solution improves functional and biochemical characteristics of buffy-coat platelet concentrates stored for 7 days, with or without INTERCEPT pathogen reduction
    Isola, Herve
    Ravanat, Catherine
    Rudwill, Floriane
    Pongerard, Anais
    Haas, Delphine
    Eckly, Anita
    Gachet, Christian
    Hechler, Beatrice
    TRANSFUSION, 2021, 61 (03) : 919 - 930
  • [50] In Vitro Cell Quality Tests of Buffy Coat Platelets in Additive Solution Treated with Mirasol Pathogen Reduction Technology
    Ostrowski, S. R.
    Bochsen, L.
    Salado-Jimena, J. A.
    Ullum, H.
    Reynaerts, I.
    Goodrich, R. P.
    Johansson, P. I.
    TRANSFUSION, 2009, 49 : 93A - 94A